ignyt is the playbook’s proprietary customer development system that builds the evidence and drives the decision-making to grow and scale life science ventures.

Ignyt helps founders turn customer discovery and sales learning into validated product strategy, a repeatable sales motion, and a winning investment proposition

Ignyt fuels milestone-driven life science companies to make high-stakes commercialization decisions from structured, traceable customer evidence. It creates a shared operating system for what the company believes, what the market is demonstrating, what has changed, and what should happen next.

Who ignyt is designed for

Ignite is designed for companies with a working technical asset and consequential commercialization milestones within the next three to nine months. Typical triggers include a funding round, grant commercialization plan, first pilot, market-entry decision, pricing decision, or first commercial hire.

• Seed and Series A ventures preparing to turn founder-led selling into an institutional capability

• NIH Phase I and Phase II companies strengthening commercialization plans and market evidence

• Early-revenue companies preparing for their first sales or business-development hire

• Health-tech companies navigating complex customer workflows and stakeholder groups

• Diagnostics, precision-medicine, med-tech, and research-tool companies balancing technical proof with buying evidence

• Investors, accelerators, and translational programs seeking a consistent way to evaluate and strengthen portfolio commercialization readiness

ignyt Customer
Development System

Contact Us for ignyt Pricing